Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Total 13F shares
-
46,974,230
-
Share change
-
+46,974,200
-
Total reported value
-
$1,714,334,294
-
Price per share
-
$36.50
-
Number of holders
-
77
-
Value change
-
+$1,714,333,177
-
Number of buys
-
74
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q2 2021
As of 30 Jun 2021,
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,974,230 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, Laurion Capital Management LP, VANGUARD GROUP INC, ARK Investment Management LLC, FMR LLC, HARVARD MANAGEMENT CO INC, CREDIT SUISSE AG/, BlackRock Inc., MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.